Literature DB >> 10811838

Proving HIV-1 immunity: new tools offer new opportunities.

L J Picker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10811838      PMCID： PMC315471          DOI： 10.1172/JCI10049

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  12 in total

1.  HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death.

Authors:  S J Brodie; B K Patterson; D A Lewinsohn; K Diem; D Spach; P D Greenberg; S R Riddell; L Corey
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

2.  HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression.

Authors:  C J Pitcher; C Quittner; D M Peterson; M Connors; R A Koup; V C Maino; L J Picker
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

3.  T-cell epitope mapping by flow cytometry.

Authors:  F Kern; I P Surel; C Brock; B Freistedt; H Radtke; A Scheffold; R Blasczyk; P Reinke; J Schneider-Mergener; A Radbruch; P Walden; H D Volk
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

4.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

5.  Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

Authors:  D T Evans; D H O'Connor; P Jing; J L Dzuris; J Sidney; J da Silva; T M Allen; H Horton; J E Venham; R A Rudersdorf; T Vogel; C D Pauza; R E Bontrop; R DeMars; A Sette; A L Hughes; D I Watkins
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

6.  Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors.

Authors:  S L Rowland-Jones; T Dong; L Dorrell; G Ogg; P Hansasuta; P Krausa; J Kimani; S Sabally; K Ariyoshi; J Oyugi; K S MacDonald; J Bwayo; H Whittle; F A Plummer; A J McMichael
Journal:  Immunol Lett       Date:  1999-03       Impact factor: 3.685

Review 7.  Can the immune response control HIV infection?

Authors:  W E Paul
Journal:  Cell       Date:  1995-07-28       Impact factor: 41.582

8.  Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.

Authors:  E S Rosenberg; J M Billingsley; A M Caliendo; S L Boswell; P E Sax; S A Kalams; B D Walker
Journal:  Science       Date:  1997-11-21       Impact factor: 47.728

9.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

10.  In vivo migration and function of transferred HIV-1-specific cytotoxic T cells.

Authors:  S J Brodie; D A Lewinsohn; B K Patterson; D Jiyamapa; J Krieger; L Corey; P D Greenberg; S R Riddell
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440
View more
  1 in total

1.  Structure and immunogenicity of alternative forms of the simian immunodeficiency virus gag protein expressed using Venezuelan equine encephalitis virus replicon particles.

Authors:  Chad Cecil; Ande West; Martha Collier; Christy Jurgens; Victoria Madden; Alan Whitmore; Robert Johnston; Dominic T Moore; Ronald Swanstrom; Nancy L Davis
Journal:  Virology       Date:  2007-02-01       Impact factor: 3.616
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.